Prophylactic pegfilgrastim to prevent febrile neutropenia among patients receiving biweekly (Q2W) chemotherapy regimens: a systematic review of efficacy, effectiveness and safety.
Reshma L MahtaniJeffrey CrawfordSinéad M FlanneryTatiana LawrenceJennifer SchenfeldPrasad L GawadePublished in: BMC cancer (2021)
PROSPERO registration no: CRD42019155572 .